Frost & Sullivan

OCTOBER 1, 2024

LabVantage Solutions’ strategic partnerships, specialized solutions, and regulatory compliance improve data security and serve various industries, including pharmaceuticals, biotechnology, food and beverage, oil and gas, forensics, academia, and the public sector.

Life science 104

Life science Biotechnology Consumer packaged goods Strategic partnership 104

Jake Jorgovan

NOVEMBER 20, 2023

They offer expertise in areas like healthcare operations, digital transformation, and strategic partnerships. BioBridges BioBridges , a clinical operations consulting firm, specializes in managing and overseeing clinical trials. Chartis Chartis is a healthcare advisory firm providing consulting services across the healthcare continuum.

Life science 130

Life science Mergers and acquisition activities Biotechnology Biotech 130

Jake Jorgovan

NOVEMBER 28, 2023

MWA Consulting: Is dedicated to upholding GXP quality and regulatory compliance in the pharmaceutical, medical device, and biotechnology industries. MWA Consulting MWA Consulting is dedicated to upholding GXP quality and regulatory compliance in the pharmaceutical, medical device, and biotechnology industries.

Life science 130

Life science Biopharmaceuticals Biotech Partnering capability and readiness 130

Frost & Sullivan

AUGUST 6, 2023

San Antonio, TX — 7 th Aug, 2023 — Frost & Sullivan recently researched the Asia-Pacific biotechnology contract research organization industry and, based on its findings, recognizes Avance Clinical with the 2023 Customer Value Leadership Award.

Biotechnology 52

Biotechnology Biotech Contract research organization Biopharmaceuticals 52

Frost & Sullivan

JANUARY 17, 2023

To reap the advantage of the expanding sustainable agrochemicals sector, agriculture technology developers should: Focus on strategic partnerships and mergers and acquisitions with biotechnology market players to accelerate formulation development. Form strategic partnerships for new product development.

Biotechnology 52

Biotechnology Strategic partnership Government Collaboration 52

Frost & Sullivan

MARCH 28, 2025

The pharmaceutical and biotechnology industries are at the cusp of a transformative era in 2025, driven by cutting-edge innovation, evolving regulations, and increasing market pressures. “The pharmaceutical and biotechnology industries are at a pivotal moment, where cutting-edge innovation meets increasing market demands.

Biotech 52

Biotech Biotechnology Strategic partnership Insurance 52

Frost & Sullivan

FEBRUARY 24, 2025

The global healthcare landscape is undergoing a significant shift, driven by antimicrobial resistance (AMR), emerging pathogens, and biotechnology advancements. Biotechnology Innovations: Advances in RNA interference (RNAi), CRISPR gene editing, and multispecific antibodies are transforming how we approach infectious disease treatment.

Biotechnology 52

Biotechnology Biopharmaceuticals Strategic partnership 52